Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

2017 In Review: FDA's Cosmetics Slowdown Could Bolster Case For Legislative Jumpstart

Executive Summary

FDA's cosmetics activities fell off noticeably compared with 2016, and the change in the White House spurred the agency to begin looking for regulatory burdens to eliminate while shuffling priorities away from cosmetics to make do with proposed cuts in federal funding. In this climate, robust cosmetics oversight may depend on a legislative update, with multiple draft bills on the table.

Advertisement

Related Content

2017 In Review: Plaintiffs Find New Angles For Attacking Cosmetics' Authenticity
ICMAD Stands By House Cosmetics Bill, But May Be Ready To Negotiate
Surprise Hatch Bill Lays Middle Ground For Cosmetic Regulatory Reform
Cosmetics Reg Reform Ill-Situated As Trump, FDA Explore 'Burden Reduction'
Skin 2 Spirit Scrubs Acne Claims On FDA Warning; Moon Valley Psoriasis Claim Persists
Rep. Pallone Galvanized By FDA's 'Troubling Overview' Of Cosmetic Imports
FDA To Curtail Cosmetics Safety Work Under FY 2018 Budget Constraints
Cosmetics Reform Bill Relaunches In Senate, Sending Stakeholders To Familiar Corners
FDA Warnings Slow, But Anti-Aging Claims Remain Class Action Targets
FDA Seeks Info From Injured WEN Users, Docs As Investigation Continues

Topics

Advertisement
UsernamePublicRestriction

Register

RS121391

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel